SIGA Technologies (SIGA) Competitors $6.16 -0.10 (-1.60%) Closing price 04:00 PM EasternExtended Trading$6.16 0.00 (-0.08%) As of 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends SIGA vs. AMPH, BLTE, SDGR, ARQT, IRON, INDV, GPCR, IMCR, TVTX, and GLPGShould you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Amphastar Pharmaceuticals (AMPH), Belite Bio (BLTE), Schrödinger (SDGR), Arcutis Biotherapeutics (ARQT), Disc Medicine (IRON), Indivior (INDV), Structure Therapeutics (GPCR), Immunocore (IMCR), Travere Therapeutics (TVTX), and Galapagos (GLPG). These companies are all part of the "pharmaceutical products" industry. SIGA Technologies vs. Amphastar Pharmaceuticals Belite Bio Schrödinger Arcutis Biotherapeutics Disc Medicine Indivior Structure Therapeutics Immunocore Travere Therapeutics Galapagos Amphastar Pharmaceuticals (NASDAQ:AMPH) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership, community ranking and valuation. Do institutionals and insiders believe in AMPH or SIGA? 65.1% of Amphastar Pharmaceuticals shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 27.1% of Amphastar Pharmaceuticals shares are owned by company insiders. Comparatively, 1.5% of SIGA Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor AMPH or SIGA? Amphastar Pharmaceuticals received 387 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 66.22% of users gave Amphastar Pharmaceuticals an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformAmphastar PharmaceuticalsOutperform Votes39266.22% Underperform Votes20033.78% SIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% Which has more volatility and risk, AMPH or SIGA? Amphastar Pharmaceuticals has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Which has stronger valuation & earnings, AMPH or SIGA? Amphastar Pharmaceuticals has higher revenue and earnings than SIGA Technologies. SIGA Technologies is trading at a lower price-to-earnings ratio than Amphastar Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmphastar Pharmaceuticals$644.40M2.74$137.54M$3.0012.25SIGA Technologies$139.92M3.19$68.07M$1.205.20 Does the media refer more to AMPH or SIGA? In the previous week, Amphastar Pharmaceuticals and Amphastar Pharmaceuticals both had 3 articles in the media. SIGA Technologies' average media sentiment score of 1.09 beat Amphastar Pharmaceuticals' score of 0.59 indicating that SIGA Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amphastar Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SIGA Technologies 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is AMPH or SIGA more profitable? SIGA Technologies has a net margin of 49.33% compared to Amphastar Pharmaceuticals' net margin of 21.80%. SIGA Technologies' return on equity of 49.06% beat Amphastar Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Amphastar Pharmaceuticals21.80% 26.44% 11.89% SIGA Technologies 49.33%49.06%38.72% Do analysts rate AMPH or SIGA? Amphastar Pharmaceuticals currently has a consensus target price of $60.33, suggesting a potential upside of 64.11%. Given Amphastar Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts clearly believe Amphastar Pharmaceuticals is more favorable than SIGA Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amphastar Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50SIGA Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAmphastar Pharmaceuticals beats SIGA Technologies on 11 of the 17 factors compared between the two stocks. Get SIGA Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$445.89M$6.89B$5.62B$9.13BDividend YieldN/A2.95%5.36%3.98%P/E Ratio5.2010.0189.4917.56Price / Sales3.19348.721,226.9482.83Price / Cash6.6265.0944.3037.67Price / Book2.255.305.134.74Net Income$68.07M$154.95M$117.78M$224.51M7 Day Performance-3.48%3.33%2.11%-0.19%1 Month Performance5.49%3.39%10.27%4.66%1 Year Performance26.42%8.15%26.92%19.44% SIGA Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASIGA Technologies2.2622 of 5 stars$6.16-1.6%N/A+24.2%$439.82M$139.92M5.1340Positive NewsAMPHAmphastar Pharmaceuticals4.7206 of 5 stars$37.11+1.7%$60.33+62.6%-34.2%$1.78B$644.40M12.371,761Short Interest ↑BLTEBelite Bio3.4072 of 5 stars$57.33-3.5%$96.33+68.0%+26.1%$1.77BN/A-51.6510Short Interest ↓News CoverageSDGRSchrödinger1.8323 of 5 stars$24.07-2.4%$32.11+33.4%-11.6%$1.75B$216.67M-10.29790ARQTArcutis Biotherapeutics1.8116 of 5 stars$14.24+2.8%$16.60+16.6%+126.4%$1.67B$59.61M-7.95150Short Interest ↓Positive NewsIRONDisc Medicine3.1122 of 5 stars$55.96-2.6%$88.90+58.9%-14.3%$1.67BN/A-14.0630Short Interest ↑INDVIndivior2.7548 of 5 stars$12.02+0.3%$16.00+33.1%-31.0%$1.66B$1.09B-300.421,164Analyst ForecastShort Interest ↑News CoverageGPCRStructure Therapeutics2.3175 of 5 stars$28.40+0.6%$81.29+186.2%-29.7%$1.63BN/A-38.38136Short Interest ↑IMCRImmunocore1.8931 of 5 stars$32.26-2.2%$65.64+103.5%-56.1%$1.61B$249.43M-33.96320Analyst ForecastAnalyst RevisionPositive NewsTVTXTravere Therapeutics2.1461 of 5 stars$20.13-0.9%$24.00+19.2%+119.4%$1.57B$145.24M-4.42460Analyst RevisionGLPGGalapagos1.6786 of 5 stars$23.61-0.4%$30.75+30.2%-39.5%$1.56B$259.40M0.001,123 Related Companies and Tools Related Companies Amphastar Pharmaceuticals Alternatives Belite Bio Alternatives Schrödinger Alternatives Arcutis Biotherapeutics Alternatives Disc Medicine Alternatives Indivior Alternatives Structure Therapeutics Alternatives Immunocore Alternatives Travere Therapeutics Alternatives Galapagos Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SIGA) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SIGA Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SIGA Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIGA Stock Alerts